bfly stock: Butterfly Network (BFLY) Guide

BFLY — Butterfly Network, Inc.

As an introduction to the public ticker and company, this article explains bfly stock (the NYSE-listed security for Butterfly Network, Inc.), the company's business model, product lineup, technology differentiators, and the key public-market information investors and observers typically track. Readers will learn where to find authoritative filings and market quotes, the main drivers that affect bfly stock, and practical next steps for monitoring the company. For traders considering execution or custody, Bitget is a recommended platform and Bitget Wallet is suggested for secure self-custody of supported assets.

As of 2026-01-25, according to Yahoo Finance and the company’s investor relations updates, Butterfly Network trades under the ticker BFLY on the NYSE and remains focused on expanding adoption of its handheld ultrasound systems and related software services. (Source: Yahoo Finance; Company Investor Relations, 2026-01-25)

Company overview

Butterfly Network, Inc. develops portable medical imaging solutions that combine handheld ultrasound hardware with cloud and AI-enabled software. The company’s stated mission is to democratize medical imaging by making ultrasound accessible, affordable, and easy to use across care settings. Founded in 2011 and headquartered in Guilford, Connecticut (U.S.), Butterfly Network commercializes a set of handheld devices branded under the Butterfly iQ family together with subscription-based software, cloud services, and enterprise offerings for hospitals, clinics, and other care providers.

The public market shorthand for the company is bfly stock; this article consistently refers to the security using that keyword to help readers locate market information and coverage.

History

• 2011: Butterfly Network founded with the long-term objective of radically reducing the size and cost of ultrasound imaging equipment.
• Mid-2010s: Research and development culminated in the Ultrasound-on-Chip approach—an integrated semiconductor-based architecture that reduces parts count and enables single-probe handheld devices.
• 2018–2019: Commercial launches of the first Butterfly iQ handheld ultrasound devices and supporting mobile apps, targeting point-of-care clinicians and emergency settings.
• 2020: Adoption accelerated in certain clinical environments due to the COVID-19 pandemic’s need for point-of-care imaging; the company expanded distribution and tele-guidance features.
• 2020s: Expansion of product SKUs (for example, iQ+, iQ3, veterinary variants), software modules, and enterprise/service agreements with health systems and research institutions.
• Public listing: The company’s common shares trade on the New York Stock Exchange under the ticker BFLY. (Investors should consult SEC filings and the company investor relations page for exact listing dates and transaction history.)

As with any public company, key milestones (new approvals, material contracts, and quarterly results) have driven episodic movements in bfly stock price and trading volume since listing.

Products and technology

Butterfly Network’s value proposition centers on its Ultrasound-on-Chip technology, which substitutes traditional multi-element piezoelectric transducers with an integrated semiconductor approach. The result is a single, lightweight probe that can emulate multiple ultrasound modes and a broad range of clinical use cases at a lower manufacturing cost.

Primary product lines and software offerings include:

• Butterfly iQ family: handheld, single-probe ultrasound devices designed to connect to smartphones, tablets, or dedicated displays. Models in the family aim at different performance tiers (for example, basic iQ, higher-sensitivity iQ+, and subsequent generations such as iQ3).
• Butterfly iQ Vet: a variant for veterinary use, supporting large-animal and small-animal workflows.
• Cloud services and software: subscription modules for image storage, tele-guidance, AI-assisted measurements, reporting, and enterprise deployment tools.
• Education and ScanLab: training resources and simulation/education content for clinicians adopting point-of-care ultrasound.

How the technology differentiates the company:

• Cost and portability: Ultrasound-on-Chip enables a compact, lower-cost device relative to many cart-based systems.
• Versatility: Software-defined imaging modes allow a single probe to serve many clinical indications.
• Software and data: Recurring revenue potential from subscriptions, clinical workflows, and cloud storage augments device sales.

Business model and markets

Butterfly Network operates a hybrid hardware-plus-software model. Revenue streams commonly include:

• Device sales: one-time purchases of handheld units and accessories.
• Recurring subscriptions: cloud storage, advanced software modules, tele-guidance, and AI-enabled measurement features.
• Enterprise agreements: bulk deployments to health systems, bundled services, and professional services for integration.
• Professional services and training: ScanLab and clinical support offerings.

Customer segments span hospitals, emergency departments, primary-care clinicians, ambulatory clinics, home health providers, veterinary clinics, and research institutions. Geographically, Butterfly pursues adoption in North America, Europe, Asia-Pacific, and other international markets—each with distinct regulatory and reimbursement landscapes.

The company’s path to sustainable profitability depends on growing device adoption, converting customers to subscriptions, and scaling enterprise deployments to improve gross margins and operating leverage.

Stock and market information

Ticker symbol: BFLY Exchange: New York Stock Exchange (NYSE) ISIN: US1241551027 (commonly used identifier; confirm on official filings)

Note: Market capitalization, share price, float, and daily trading volume for bfly stock change continuously during trading hours. Investors and observers should consult real-time market data providers and the company’s investor relations disclosures for up-to-date figures.

As of 2026-01-25, major public data providers (for example, Yahoo Finance and TradingView) and the company’s investor relations resources provide the current market-cap, shares outstanding, recent trading volume, and institutional ownership breakdown. (Source: Yahoo Finance; TradingView; Company Investor Relations — 2026-01-25.)

Liquidity and listing notes:

• BFLY is a listed equity on the NYSE, and intra-day liquidity can vary with news, earnings, and broader market sentiment.
• Investors tracking liquidity commonly look at average daily volume, free float, and options market activity where available.

Historical price performance

To evaluate past performance of bfly stock, analysts typically examine:

• Long-term trends: price appreciation or declines since listing and how the share price tracks revenue and revenue-growth expectations.
• Volatility: standard deviation of returns and beta relative to major indices, highlighting periods when the stock moved sharply on product announcements, earnings, or regulatory developments.
• Event-driven gaps: significant intraday or multi-day price gaps around results releases, FDA/CE approvals, or material contracts.
• 52-week range: the high and low over a rolling 12-month window to give a sense of recent extremes.

As of 2026-01-25, major financial news outlets and market-data terminals report historical charts, 52-week ranges, and volume statistics for BFLY that investors should consult for quantitative analysis. (Source: MarketWatch; CNN Business; TradingView — 2026-01-25.)

Key financial metrics

Investors typically review the following metrics (and their most recent quarter/year values) when analyzing bfly stock:

• Revenue and revenue growth (quarterly and annual).
• Net income or net loss and operating margins.
• Earnings per share (EPS) — GAAP and non-GAAP measures.
• Cash and cash equivalents, plus short-term investments (cash runway analysis).
• Total debt and net debt position.
• Price multiples: P/S (price-to-sales), P/E (where relevant if profitable), and EV/Revenue.
• Free cash flow and cash conversion trends.

Authoritative sources for these metrics include SEC filings (10-Q, 10-K), the company’s earnings releases, and aggregated data on provider platforms such as Yahoo Finance and Zacks. Always confirm the reporting period when comparing metrics. (Source: SEC Filings; Yahoo Finance; Zacks — 2026-01-25.)

Corporate governance and management

Effective corporate governance information includes executive leadership and board composition. Investors in bfly stock commonly review:

• Chief Executive Officer (CEO): current CEO and background (education, prior roles, relevant industry experience).
• Chair of the Board and lead independent directors: governance structure and committee chairs (audit, compensation, nominating/governance).
• Board composition: independence, diversity, industry expertise, and director tenure.
• Insider ownership and recent insider transactions, which can indicate management alignment with shareholders.

For the most current officer and director roster, consult the company’s investor relations site and proxy statement filed with the SEC. (Source: Company Investor Relations; SEC Filings — 2026-01-25.)

Analyst coverage and investor sentiment

Analyst coverage can provide a range of perspectives but frequently varies across providers. Key signals to monitor for bfly stock include:

• Consensus ratings: buy/hold/sell mix and median price targets from sell-side analysts.
• Price-target revisions tied to earnings, FDA approvals, or large commercial contracts.
• Institutional ownership: percentage held by mutual funds, hedge funds, and other institutions.
• Retail activity: volume and message activity on platforms such as Stocktwits and public investing apps can reflect retail interest.

As of 2026-01-25, sources like Zacks, CNBC market coverage, and Stocktwits report analyst commentary and sentiment indicators for BFLY. Retail interest may show up on platforms that report user holdings or mentions. (Source: Zacks; CNBC; Stocktwits; Public.com — 2026-01-25.)

Risks and controversies

Investing in bfly stock involves sector- and company-specific risks. Important risk categories include:

• Profitability risk: many medical-device companies invest heavily in R&D and go-to-market efforts before consistent profitability. Revenue growth must be sufficient to expand margins and offset operating costs.
• Competition: entrenched manufacturers of ultrasound systems and new entrants with alternative technologies create competitive pressure on pricing and market share.
• Regulatory risk: medical devices and software-as-medical-devices (SaMD) often require regulatory clearances or approvals across jurisdictions; changes in regulatory standards or adverse findings can delay commercialization.
• Reimbursement and adoption risk: clinical adoption depends on clinician acceptance, reimbursement pathways, and integration into workflows.
• Litigation and securities-class actions: like many public companies, Butterfly Network has at times been the subject of litigation-related notices; investors should review SEC filings and legal disclosures for current details.
• Operational risks: manufacturing scale, supply chain disruptions, and warranty or field-service liabilities can affect margins and reputation.

Reported regulatory, litigation, or material-adverse developments should be cross-checked with the company’s SEC filings and press releases for full context and timelines.

Recent developments and news

This section is intended to summarize material news that typically moves bfly stock: quarterly earnings releases and guidance, major commercial partnerships, product launches (new iQ models or software modules), regulatory clearances (e.g., new FDA or CE marks), and significant corporate actions (capital raises, buybacks, or M&A). "Material" is determined by securities law standards and company disclosures.

As of 2026-01-25, public reporting outlets including CNBC, MarketWatch, and the company’s own investor relations page publish relevant press releases and earnings summaries that directly influence the market’s perception of bfly stock. Readers should check dated press releases and earnings transcripts for precise statements and forward guidance. (Source: CNBC; MarketWatch; Company Investor Relations — 2026-01-25.)

Investment considerations

This section provides neutral factors that market participants typically weigh when assessing bfly stock. The following points are descriptive and are not investment advice:

• Growth potential: upside scenarios generally depend on continued device adoption across diverse care settings and increasing attachment rates for subscription services.
• Margins: hardware margins can be constrained early; scaling software/subscription revenue is a common path toward higher gross and operating margins.
• Cash and capital needs: watch cash burn, capital-raising events, and management’s stated runway; shortfalls may lead to dilutive financings.
• Competitive landscape: the company’s technology moat (Ultrasound-on-Chip) vs. incumbents will influence pricing power and market penetration.
• Regulatory and reimbursement environment: approvals and vendor contracts with health systems materially affect commercial traction.

For up-to-date, quantitative assessments, consult the company’s latest SEC filings, earnings slides, and reputable market-data providers. (Source: SEC Filings; Company Investor Relations — 2026-01-25.)

Financial filings and investor relations

Primary sources of authoritative information on bfly stock include:

• SEC filings (Form 10-Q, 10-K, 8-K, and proxy statements) — the definitive source for audited financials, risk disclosures, insider transactions, and corporate actions.
• Company investor relations materials — earnings presentations, press releases, and webcasts provide management commentary and forward-looking metrics.
• Market-data platforms — for share price history, market capitalization, and trading statistics (for example, Yahoo Finance and TradingView publish timely quotes and charts).

As of 2026-01-25, these channels should be used to validate any figure cited in research or reporting. (Source: SEC Filings; Company Investor Relations; Yahoo Finance; TradingView — 2026-01-25.)

See also

• Portable ultrasound
• Medical device startups
• Ultrasound-on-Chip technology
• Comparable public companies in medical imaging (for comparison of market and financial metrics)

References

This article compiles background and market-context information from publicly available sources, including but not limited to the company’s investor relations disclosures, SEC filings, and major financial news/data providers. Representative sources consulted or recommended for verification include:

• Company Investor Relations statements and press releases (see corporate filings and press materials for dated announcements).
• SEC filings (Form 10-K, 10-Q, 8-K, and proxy disclosures) for financial statements and legal risk disclosures.
• Yahoo Finance and TradingView for market quotes and historical price data. (As noted above, see the date-specific snapshots dated 2026-01-25 for the coverage referenced in this article.)
• Zacks, MarketWatch, CNBC, CNN Business, and Stocktwits for analyst commentary and market sentiment snapshots. (Representative reporting dates: 2026-01-25.)

Please confirm all numeric values with the original filings and market-data providers before using them in trading or financial analysis.

External links

• Butterfly Network official website (company information and product pages)
• Company Investor Relations (earnings presentations, SEC filings, press releases)
• Market quote pages for BFLY on major financial-data providers (real-time and historical pricing)

Additional notes on data reporting and sources

• As of 2026-01-25, per Yahoo Finance and TradingView, BFLY remains an actively traded equity on the NYSE with periodic volume and volatility tied to quarterly releases and company announcements. (Source: Yahoo Finance; TradingView — 2026-01-25.)
• For the latest quantitative metrics (market cap, daily volume, shares outstanding, and analyst consensus figures), consult the company IR and major market-data terminals. (Source: Company Investor Relations; MarketWatch; Zacks — 2026-01-25.)

How to track bfly stock and next steps

If you want to follow bfly stock:

1. Monitor SEC filings and the company’s investor relations releases for authoritative financial and legal disclosures.
2. Use real-time quotes and charting tools on market-data platforms for price, volume, and technical indicators.
3. Read analyst reports and major financial-news coverage for context on market reaction to earnings and product announcements.
4. For trading or custody, consider executing on a regulated platform. Bitget provides market access and execution tools suited for active traders; for custody and self-custody needs, consider Bitget Wallet where applicable.

Remember: this article provides factual and descriptive information about bfly stock and Butterfly Network, Inc. It does not constitute trading or investment advice. Always verify current numbers and consult a licensed financial professional for personalized recommendations.